Invention Grant
![Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors](/docs/US/2020-09-08/US10766897B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
-
Application No.: US16542792Application Date: 2019-08-16
-
Publication No.: US10766897B2Publication Date: 2020-09-08
- Inventor: Max Espensen , Lee Patient , David Evans , Iain Simpson , Edward Savory
- Applicant: PROXIMAGEN, LLC
- Applicant Address: US MN Plymouth
- Assignee: PROXIMAGEN, LLC
- Current Assignee: PROXIMAGEN, LLC
- Current Assignee Address: US MN Plymouth
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1d62a54d
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/40 ; A61K31/4745 ; A61K31/495 ; A61K31/501 ; A61K31/506 ; C07C53/18
![Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors](/abs-image/US/2020/09/08/US10766897B2/abs.jpg.150x150.jpg)
Abstract:
The compounds of formula (I) are inhibitors of SSAO activity wherein V, W, X, Y, Z, R1 and R2 are as defined in the claims.
Public/Granted literature
- US20200002335A1 IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS Public/Granted day:2020-01-02
Information query
